Olivia Buraks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olivia Buraks has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Janet Mullington
Beth Israel Deaconess Medical Center
4 shared publications- Michael Vazquez
Beth Israel Deaconess Medical Center
4 shared publications Monika Haack
Beth Israel Deaconess Medical Center and Harvard Medical School
4 shared publicationsHuan Yang
Beth Israel Deaconess Medical Center
3 shared publicationsMichael Goldstein
Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School
2 shared publicationsAlicia Stokes
Beth Israel Deaconess Medical Center
1 shared publication
Latest Publications
- Open Access
- 11 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (4) , 3180
Dismantling the Component-Specific Effects of Yogic Breathing: Feasibility of a Fully Remote Three-Arm RCT with Virtual Laboratory Visits and Wearable Physiology
Despite the growing research base examining the benefits and physiological mechanisms of slow-paced breathing (SPB), mindfulness (M), and their combination (as yogic breathing, SPB + M), no studies have directly compared these in a ”dismantling” framework. To address this gap, we conducted a fully remote three-armed feasibility study with wearable devices and video-based laboratory visits. Eighteen healthy participants (age 18–30 years, 12 female) were randomized to one of three 8-week interventions: slow-paced breathing (SPB, N = 5), mindfulness (M, N = 6), or yogic breathing (SPB + M, N = 7). The participants began a 24-h heart rate recording with a chest-worn device prior to the first virtual laboratory visit, consisting of a 60-min intervention-specific training with guided practice and experimental stress induction using a Stroop test. The participants were then instructed to repeat their assigned intervention practice daily with a guided audio, while concurrently recording their heart rate data and completing a detailed practice log. The feasibility was determined using the rates of overall study completion (100%), daily practice adherence (73%), and the rate of fully analyzable data from virtual laboratory visits (92%). These results demonstrate feasibility for conducting larger trial studies with a similar fully remote framework, enhancing the ecological validity and sample size that could be possible with such research designs.
- 11 February 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (4) , 3180
Open AccessDismantling the Component-Specific Effects of Yogic Breathing: Feasibility of a Fully Remote Three-Arm RCT with Virtual Laboratory Visits and Wearable Physiology
Despite the growing research base examining the benefits and physiological mechanisms of slow-paced breathing (SPB), mindfulness (M), and their combination (as yogic breathing, SPB + M), no studies have directly compared these in a ”dismantling” framework. To address this gap, we conducted a fully remote three-armed feasibility study with wearable devices and video-based laboratory visits. Eighteen healthy participants (age 18–30 years, 12 female) were randomized to one of three 8-week interventions: slow-paced breathing (SPB, N = 5), mindfulness (M, N = 6), or yogic breathing (SPB + M, N = 7). The participants began a 24-h heart rate recording with a chest-worn device prior to the first virtual laboratory visit, consisting of a 60-min intervention-specific training with guided practice and experimental stress induction using a Stroop test. The participants were then instructed to repeat their assigned intervention practice daily with a guided audio, while concurrently recording their heart rate data and completing a detailed practice log. The feasibility was determined using the rates of overall study completion (100%), daily practice adherence (73%), and the rate of fully analyzable data from virtual laboratory visits (92%). These results demonstrate feasibility for conducting larger trial studies with a similar fully remote framework, enhancing the ecological validity and sample size that could be possible with such research designs.
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A129-A130
0287 Effects of Sleep Restriction and Recovery on the Capacity of Glucocorticoids to Inhibit Inflammatory Marker Expression in Human Monocytes
Introduction: Chronic low-grade systemic inflammation is involved in the pathogenesis of many human diseases. Common sleep patterns of restricting sleep during weekdays and catching up on sleep over the weekend induce inflammatory upregulation that may not resolve following weekend recovery sleep. We hypothesize that this sleep pattern leads to an inflammatory imbalance of markers regulating inflammatory homeostasis, including inflammatory markers (eg, interleukin-6 (IL-6) and cyclooxygenase 2 (COX-2)) and markers of counter-inflammation (eg, glucocorticoids (GCs)). The enzyme COX-2 is involved in prostaglandin synthesis and is the target of pain-relieving nonsteroidal anti-inflammatory drugs (NSAIDs). GCs are used in the treatment of many inflammatory diseases, including severe acute infection with SARS-CoV-2. We investigated if sleep restriction impairs the capacity of GCs to inhibit inflammatory COX-2 expression in a preliminary dataset. Methods: The present preliminary dataset (N=6, 2F/4M) derives from an ongoing randomized controlled within-subjects trial consisting of three 11-day in-hospital protocols (2 restricted sleep arms, 1 control sleep arm). The ongoing study is blinded for administration of placebo or aspirin under sleep restriction. Under restricted sleep conditions, 2 nights of baseline sleep (8h/night) were followed by 5 nights of restricted sleep (4h/night), concluding with 3 nights of recovery sleep (8h/night). In the control condition, participants could sleep 8h/night throughout the entire protocol. Blood samples were taken after baseline sleep, after 5 nights of restricted or control sleep, and after 2 nights of recovery sleep. Data were analyzed using generalized linear mixed models. Results: Sleep restriction was associated with decreased capacity of GCs to inhibit COX-2 expression in monocytes (p<.01) and has the expected inflammatory effect on IL-6 production in monocytes (p<.01). Moreover, sleep restriction has lasting inflammatory effects as shown in increased inflammation following 2 nights of recovery sleep (p<.01). Conclusion: In conclusion, the present preliminary analysis suggests that in patients treated with GCs, sleep restriction potentially reduces their effectiveness in controlling inflammation, thus contributing to increased inflammation-related morbidity. Sample collection and data analysis is ongoing. Support (If Any): NIH/NHLBI R01-HL136310; NIH/NCRR UL1-RR02758, M01-RR01032; German Research Foundation (DFG) EN1291/1-1.
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A129-A130
0287 Effects of Sleep Restriction and Recovery on the Capacity of Glucocorticoids to Inhibit Inflammatory Marker Expression in Human Monocytes
Introduction: Chronic low-grade systemic inflammation is involved in the pathogenesis of many human diseases. Common sleep patterns of restricting sleep during weekdays and catching up on sleep over the weekend induce inflammatory upregulation that may not resolve following weekend recovery sleep. We hypothesize that this sleep pattern leads to an inflammatory imbalance of markers regulating inflammatory homeostasis, including inflammatory markers (eg, interleukin-6 (IL-6) and cyclooxygenase 2 (COX-2)) and markers of counter-inflammation (eg, glucocorticoids (GCs)). The enzyme COX-2 is involved in prostaglandin synthesis and is the target of pain-relieving nonsteroidal anti-inflammatory drugs (NSAIDs). GCs are used in the treatment of many inflammatory diseases, including severe acute infection with SARS-CoV-2. We investigated if sleep restriction impairs the capacity of GCs to inhibit inflammatory COX-2 expression in a preliminary dataset. Methods: The present preliminary dataset (N=6, 2F/4M) derives from an ongoing randomized controlled within-subjects trial consisting of three 11-day in-hospital protocols (2 restricted sleep arms, 1 control sleep arm). The ongoing study is blinded for administration of placebo or aspirin under sleep restriction. Under restricted sleep conditions, 2 nights of baseline sleep (8h/night) were followed by 5 nights of restricted sleep (4h/night), concluding with 3 nights of recovery sleep (8h/night). In the control condition, participants could sleep 8h/night throughout the entire protocol. Blood samples were taken after baseline sleep, after 5 nights of restricted or control sleep, and after 2 nights of recovery sleep. Data were analyzed using generalized linear mixed models. Results: Sleep restriction was associated with decreased capacity of GCs to inhibit COX-2 expression in monocytes (p<.01) and has the expected inflammatory effect on IL-6 production in monocytes (p<.01). Moreover, sleep restriction has lasting inflammatory effects as shown in increased inflammation following 2 nights of recovery sleep (p<.01). Conclusion: In conclusion, the present preliminary analysis suggests that in patients treated with GCs, sleep restriction potentially reduces their effectiveness in controlling inflammation, thus contributing to increased inflammation-related morbidity. Sample collection and data analysis is ongoing. Support (If Any): NIH/NHLBI R01-HL136310; NIH/NCRR UL1-RR02758, M01-RR01032; German Research Foundation (DFG) EN1291/1-1.
- Open Access
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A267
0609 Sleep Stabilization in Prehypertensive/Hypertensive Patients
Introduction: Variable sleep/wake patterns have been linked to increased cardiometabolic risk. The current project investigates the effects of using sleep hygiene interventions to stabilize sleep timing in prehypertensive/hypertensive patients. Growing evidence supports the importance of regularizing sleep timing in improving cardiovascular health, and we believe that using sleep hygiene techniques to stabilize sleep may reduce these risks. Methods: As part of a larger study, fifty-three participants (55.5 ± 1.4 years; 51% male) completed sleep diaries during 3 study periods. The first period (S1) was a baseline control, the second period (S2) was a 4-week wait-list control condition, and the third period (S3) was an 8-week randomly assigned intervention that used sleep hygiene approaches and scheduling to stabilize sleep timing or stabilize and lengthen sleep. Currently, we are still blind to condition; however, because both conditions involve sleep stabilization, an analysis using linear mixed models was used to assess change in the variability of total sleep time (SDTST), wake up time (SDWUT), and fall asleep time (SDFAT) across the 3 study periods. Results: There was a significant decrease in SDTST variability (standard deviation) at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was also a significant decrease in SDWUT variability at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was a trend towards a significantly decreased SDFAT at S3 compared to S2 (p=0.057), but there was a significant decrease in SDFAT variability during S3 compared to S1 (p<0.01). Conclusion: These data suggest that we were able to utilize sleep hygiene interventions to decrease the variability in total sleep time, wake-up time and fall asleep time. When we unblind we will report on if we were able to increase and lengthen the sleep period for those in the sleep extension condition. Support (If Any): NIH (R01HL125379 to Dr. Janet Mullington), Harvard Catalyst, Harvard Clinical and Translational Science Center (UL1TR001102)
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A267
Open Access0609 Sleep Stabilization in Prehypertensive/Hypertensive Patients
Introduction: Variable sleep/wake patterns have been linked to increased cardiometabolic risk. The current project investigates the effects of using sleep hygiene interventions to stabilize sleep timing in prehypertensive/hypertensive patients. Growing evidence supports the importance of regularizing sleep timing in improving cardiovascular health, and we believe that using sleep hygiene techniques to stabilize sleep may reduce these risks. Methods: As part of a larger study, fifty-three participants (55.5 ± 1.4 years; 51% male) completed sleep diaries during 3 study periods. The first period (S1) was a baseline control, the second period (S2) was a 4-week wait-list control condition, and the third period (S3) was an 8-week randomly assigned intervention that used sleep hygiene approaches and scheduling to stabilize sleep timing or stabilize and lengthen sleep. Currently, we are still blind to condition; however, because both conditions involve sleep stabilization, an analysis using linear mixed models was used to assess change in the variability of total sleep time (SDTST), wake up time (SDWUT), and fall asleep time (SDFAT) across the 3 study periods. Results: There was a significant decrease in SDTST variability (standard deviation) at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was also a significant decrease in SDWUT variability at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was a trend towards a significantly decreased SDFAT at S3 compared to S2 (p=0.057), but there was a significant decrease in SDFAT variability during S3 compared to S1 (p<0.01). Conclusion: These data suggest that we were able to utilize sleep hygiene interventions to decrease the variability in total sleep time, wake-up time and fall asleep time. When we unblind we will report on if we were able to increase and lengthen the sleep period for those in the sleep extension condition. Support (If Any): NIH (R01HL125379 to Dr. Janet Mullington), Harvard Catalyst, Harvard Clinical and Translational Science Center (UL1TR001102)
- Open Access
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A39-A40
0087 Feasibility of examining component-specific effects of yogic breathing on self-report sleep metrics: A three-arm pilot RCT
Introduction: Mind-body interventions (MBIs) continue to receive widespread interest for improving sleep disturbances. This study investigated the feasibility of using an automated electronic survey system in REDCap in the context of a fully remote clinical trial study to produce detailed measures of participant adherence, daily sleep quality, and associations with physiological outcomes captured by wearable devices. Methods: Eighteen healthy participants (age 18-30 yrs, 12 female) were randomized to one of three 8-week long interventions: slow-paced breathing (SPB, N=5, 24.6 ± 2.1 years, 4 female), mindfulness (M, N=6, 23.7 ± 3.7 years, 4 female), or yogic breathing (SPB+M, N=7, 24.3 ± 3.1 years). Participants completed two weeks of daily sleep logs along with the Pittsburgh Sleep Quality Index (PSQI) prior to a virtual laboratory visit, which consisted of a 60-min intervention-specific training, including a 20-min guided practice, and subsequent tasks including experimental stress induction. Participants were then instructed to repeat their assigned intervention practice daily, selecting either the same or a similar guided audio as their initial training. After an initial video check-in appointment, participants received regular visual feedback of their data and completed weekly check-ins with the study team to improve adherence. At the end of the intervention period, participants again completed daily sleep logs and the PSQI, in addition to other outcome measures and a virtual laboratory visit. Data were analyzed using linear mixed models. Results: Sleep log adherence was over 90% in all three groups. The groups were successfully distinguishable based on HRV-derived breathing and mindfulness ratings. For the SBP+M group only, there was a trend of reduced sleep onset latency (SOL, p=.093) and a significant increase in sleep efficiency (SE, p=.025). There were no significant changes in PSQI or other sleep log measures. More detailed analysis of timecourse across these measures is ongoing. Conclusion: These findings support feasibility for a fully remote, semi-automated clinical trial study assessing component-specific effects of these MBIs on sleep in generally healthy young adults. Research evaluating MBIs for sleep in both clinical and nonclinical populations would benefit from similar study designs to examine intervention-specific components while increasing both scalability and quality control. Support (If Any): Pilot Research Grant, Osher Center for Integrative Medicine of Harvard Medical School and Brigham & Women’s Hospital; National Institutes of Health (5T32HL007901-22)
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A39-A40
Open Access0087 Feasibility of examining component-specific effects of yogic breathing on self-report sleep metrics: A three-arm pilot RCT
Introduction: Mind-body interventions (MBIs) continue to receive widespread interest for improving sleep disturbances. This study investigated the feasibility of using an automated electronic survey system in REDCap in the context of a fully remote clinical trial study to produce detailed measures of participant adherence, daily sleep quality, and associations with physiological outcomes captured by wearable devices. Methods: Eighteen healthy participants (age 18-30 yrs, 12 female) were randomized to one of three 8-week long interventions: slow-paced breathing (SPB, N=5, 24.6 ± 2.1 years, 4 female), mindfulness (M, N=6, 23.7 ± 3.7 years, 4 female), or yogic breathing (SPB+M, N=7, 24.3 ± 3.1 years). Participants completed two weeks of daily sleep logs along with the Pittsburgh Sleep Quality Index (PSQI) prior to a virtual laboratory visit, which consisted of a 60-min intervention-specific training, including a 20-min guided practice, and subsequent tasks including experimental stress induction. Participants were then instructed to repeat their assigned intervention practice daily, selecting either the same or a similar guided audio as their initial training. After an initial video check-in appointment, participants received regular visual feedback of their data and completed weekly check-ins with the study team to improve adherence. At the end of the intervention period, participants again completed daily sleep logs and the PSQI, in addition to other outcome measures and a virtual laboratory visit. Data were analyzed using linear mixed models. Results: Sleep log adherence was over 90% in all three groups. The groups were successfully distinguishable based on HRV-derived breathing and mindfulness ratings. For the SBP+M group only, there was a trend of reduced sleep onset latency (SOL, p=.093) and a significant increase in sleep efficiency (SE, p=.025). There were no significant changes in PSQI or other sleep log measures. More detailed analysis of timecourse across these measures is ongoing. Conclusion: These findings support feasibility for a fully remote, semi-automated clinical trial study assessing component-specific effects of these MBIs on sleep in generally healthy young adults. Research evaluating MBIs for sleep in both clinical and nonclinical populations would benefit from similar study designs to examine intervention-specific components while increasing both scalability and quality control. Support (If Any): Pilot Research Grant, Osher Center for Integrative Medicine of Harvard Medical School and Brigham & Women’s Hospital; National Institutes of Health (5T32HL007901-22)
- Open Access
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A46
0103 Feasibility of examining component-specific effects of yogic breathing on heart rate variability during sleep: A three-arm pilot RCT
Introduction: Wearable devices and mind-body interventions (MBIs) continue to receive widespread interest as tools for improving sleep. This study investigated the feasibility of using an automated electronic survey system and wearable heart rate (HR) monitor in the context of a fully remote clinical trial study to produce detailed measures of participant adherence, daily sleep quality, and associations with physiological outcomes captured by wearable devices. Methods: Eighteen healthy participants (age 18-30yrs, 12 female) were randomized to one of three 8-week long interventions: slow-paced breathing (SPB, N=5, 24.6 ± 2.1 years, 4 female), mindfulness (M, N=6, 23.7 ± 3.7 years, 4 female), or yogic breathing (SPB+M, N=7, 24.3 ± 3.1 years). Participants completed two weeks of daily sleep logs prior to a virtual laboratory visit, consisting of a 60-min intervention-specific training with 20-min guided practice, and subsequent tasks including experimental stress induction. Participants started a 24-hour HR recording using a Polar H10 chest strap on the night prior. Then, participants were instructed to repeat their assigned intervention practice daily, using a guided audio similar to their initial training, while concurrently recording HR data and completing a detailed practice log. HR interbeat interval data were examined with spectral analysis using full spectrograms for inspection of timecourse and frequency-specific patterns in both the nocturnal recordings and daily practice sessions. Results: Participants completed an average of 75% of daily practice sessions across the 8-week intervention period (SPB: 77%, M: 65%, SPB+M: 77%). An automated procedure was developed to analyze and visualize the timecourse of HRV-derived breathing patterns in the 754 completed practice sessions and 36 nocturnal recordings. The three groups were then successfully distinguishable based on breathing rates and mindfulness questionnaires. Nocturnal HR recordings demonstrated visually identifiable patterns of interindividual variability and intraindividual consistency. Statistical analysis is ongoing to further characterize these patterns. Conclusion: These findings support feasibility for a fully remote, semi-automated clinical trial study assessing component-specific effects of these MBIs on sleep, including detailed spectral analysis of high-quality HR data. Future studies would benefit from examining scalability of this type of study design with wearable physiology in both clinical and nonclinical populations. Support (If Any): Pilot Research Grant, Osher Center for Integrative Medicine of Harvard Medical School and Brigham & Women’s Hospital; National Institutes of Health (5T32HL007901-22)
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A46
Open Access0103 Feasibility of examining component-specific effects of yogic breathing on heart rate variability during sleep: A three-arm pilot RCT
Introduction: Wearable devices and mind-body interventions (MBIs) continue to receive widespread interest as tools for improving sleep. This study investigated the feasibility of using an automated electronic survey system and wearable heart rate (HR) monitor in the context of a fully remote clinical trial study to produce detailed measures of participant adherence, daily sleep quality, and associations with physiological outcomes captured by wearable devices. Methods: Eighteen healthy participants (age 18-30yrs, 12 female) were randomized to one of three 8-week long interventions: slow-paced breathing (SPB, N=5, 24.6 ± 2.1 years, 4 female), mindfulness (M, N=6, 23.7 ± 3.7 years, 4 female), or yogic breathing (SPB+M, N=7, 24.3 ± 3.1 years). Participants completed two weeks of daily sleep logs prior to a virtual laboratory visit, consisting of a 60-min intervention-specific training with 20-min guided practice, and subsequent tasks including experimental stress induction. Participants started a 24-hour HR recording using a Polar H10 chest strap on the night prior. Then, participants were instructed to repeat their assigned intervention practice daily, using a guided audio similar to their initial training, while concurrently recording HR data and completing a detailed practice log. HR interbeat interval data were examined with spectral analysis using full spectrograms for inspection of timecourse and frequency-specific patterns in both the nocturnal recordings and daily practice sessions. Results: Participants completed an average of 75% of daily practice sessions across the 8-week intervention period (SPB: 77%, M: 65%, SPB+M: 77%). An automated procedure was developed to analyze and visualize the timecourse of HRV-derived breathing patterns in the 754 completed practice sessions and 36 nocturnal recordings. The three groups were then successfully distinguishable based on breathing rates and mindfulness questionnaires. Nocturnal HR recordings demonstrated visually identifiable patterns of interindividual variability and intraindividual consistency. Statistical analysis is ongoing to further characterize these patterns. Conclusion: These findings support feasibility for a fully remote, semi-automated clinical trial study assessing component-specific effects of these MBIs on sleep, including detailed spectral analysis of high-quality HR data. Future studies would benefit from examining scalability of this type of study design with wearable physiology in both clinical and nonclinical populations. Support (If Any): Pilot Research Grant, Osher Center for Integrative Medicine of Harvard Medical School and Brigham & Women’s Hospital; National Institutes of Health (5T32HL007901-22)